Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments

Overview

Journal J Oncol

Specialty Oncology

Date 2019 Jul 9

PMID 31281359

Citations 60

Authors

In-Hye Ham

Dagyeong Lee

Hoon Hur

Affiliations

Soon will be listed here.

Abstract

Although the survival of gastric cancer (GC) patients has gradually improved, the outcomes of advanced GC patients remain unsatisfactory despite standard treatment with conventional chemotherapy or targeted agents. Several studies have shown that cancer-associated fibroblasts (CAFs), a major component of tumor stroma in GC, may have significant roles in GC progression and resistance to treatments. CAFs are a major source of various secreted molecules in the tumor microenvironment, which stimulate cancer cells and other noncancerous components of GC. Surprisingly, these factors could be involved in gastric carcinogenesis. Cytokines, including interleukin-6 and interleukin-11, or growth factors, such as fibroblast growth factor produced from CAFs, can directly activate GC cells and consequently lead to the development of an aggressive phenotype. Galectin-1 or hepatocyte growth factor can be involved in CAF-derived neovascularization in GC. In addition, recent studies showed that CAFs can affect tumor immunity through M2 polarization of tumor-associated macrophages. Finally, the current study aimed to introduce several inhibitory agents and evaluate their suppressive effects on CAFs in patients with GC progression. However, further studies are required to evaluate their safety and select appropriate patients for application in clinical settings.

Citing Articles

A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies.

Panahizadeh R, Panahi P, Asghariazar V, Makaremi S, Noorkhajavi G, Safarzadeh E Cancer Cell Int. 2025; 25(1):23.

PMID: 39856676 PMC: 11762578. DOI: 10.1186/s12935-025-03655-8.

Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (Review).

Yun H, Dong F, Wei X, Yan X, Zhang R, Zhang X Oncol Rep. 2024; 53(1).

PMID: 39611496 PMC: 11622107. DOI: 10.3892/or.2024.8847.

Proteomic Heterogeneity of the Extracellular Matrix Identifies Histologic Subtype-Specific Fibroblast in Gastric Cancer.

Lee H, Kwak Y, Na Y, Kim H, Park M, Jo J Mol Cell Proteomics. 2024; 23(10):100843.

PMID: 39305996 PMC: 11526087. DOI: 10.1016/j.mcpro.2024.100843.

SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.

Dong L, Li Y, Song X, Sun C, Song X BMC Cancer. 2024; 24(1):1165.

PMID: 39300373 PMC: 11411997. DOI: 10.1186/s12885-024-12907-1.

IDH2 regulates macrophage polarization and tumorigenesis by modulating mitochondrial metabolism in macrophages.

Lee S, Kim S, Kim B, Seong J, Park Y, Lee H Mol Med. 2024; 30(1):143.

PMID: 39256649 PMC: 11385829. DOI: 10.1186/s10020-024-00911-x.

References

Chapel F, Fabiani B, Davi F, Raphael M, Tepper M, Champault G . Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology. 2000; 36(3):252-61. DOI: 10.1046/j.1365-2559.2000.00843.x. View

Wu M, Shun C, Wu C, Hsu T, Lin M, Chang M . Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology. 2000; 118(6):1031-8. DOI: 10.1016/s0016-5085(00)70355-6. View

Carmeliet P, Jain R . Angiogenesis in cancer and other diseases. Nature. 2000; 407(6801):249-57. DOI: 10.1038/35025220. View

Poon R, Fan S, Wong J . Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol. 2001; 19(4):1207-25. DOI: 10.1200/JCO.2001.19.4.1207. View

Choi D, Takeuchi M, Yamamoto M, Tominaga M, Tsukamoto T, Tatematsu M . Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine. Jpn J Cancer Res. 2002; 93(9):960-7. PMC: 5927132. DOI: 10.1111/j.1349-7006.2002.tb02471.x. View

Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S . Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci. 2003; 94(1):43-9. PMC: 11160168. DOI: 10.1111/j.1349-7006.2003.tb01350.x. View

Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K . Platelet-derived growth factor is angiogenic in vivo. Growth Factors. 1992; 7(4):261-6. DOI: 10.3109/08977199209046408. View

Grogg K, Lohse C, Pankratz V, Halling K, Smyrk T . Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003; 16(7):641-51. DOI: 10.1097/01.MP.0000076980.73826.C0. View

Yashiro M, Murahashi K, Matsuoka T, Nakazawa K, Tanaka H, Osaka H . Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts. Anticancer Res. 2003; 23(5A):3899-904. View

10.

Fletcher J . Role of KIT and platelet-derived growth factor receptors as oncoproteins. Semin Oncol. 2004; 31(2 Suppl 6):4-11. DOI: 10.1053/j.seminoncol.2004.03.034. View

11.

Ostman A . PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev. 2004; 15(4):275-86. DOI: 10.1016/j.cytogfr.2004.03.002. View

12.

Chen C, Hsieh F, Cheng Y, Cheng W, Su Y, Chang K . The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett. 2004; 213(1):73-82. DOI: 10.1016/j.canlet.2004.05.020. View

13.

Heldin C, Rubin K, Pietras K, Ostman A . High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004; 4(10):806-13. DOI: 10.1038/nrc1456. View

14.

Bhowmick N, Neilson E, Moses H . Stromal fibroblasts in cancer initiation and progression. Nature. 2004; 432(7015):332-7. PMC: 3050735. DOI: 10.1038/nature03096. View

15.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

16.

Oue N, Aung P, Mitani Y, Kuniyasu H, Nakayama H, Yasui W . Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology. 2005; 69 Suppl 1:17-22. DOI: 10.1159/000086627. View

17.

Folkman J . What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990; 82(1):4-6. DOI: 10.1093/jnci/82.1.4. View

18.

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

19.

Mesker W, Junggeburt J, Szuhai K, Heer P, Morreau H, Tanke H . The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 2007; 29(5):387-98. PMC: 4617992. DOI: 10.1155/2007/175276. View

20.

Day E, Waters B, Spiegel K, Alnadaf T, Manley P, Buchdunger E . Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur J Pharmacol. 2008; 599(1-3):44-53. DOI: 10.1016/j.ejphar.2008.10.014. View